341 related articles for article (PubMed ID: 34006646)
1. Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8
Cagnoni AJ; Giribaldi ML; Blidner AG; Cutine AM; Gatto SG; Morales RM; Salatino M; Abba MC; Croci DO; Mariño KV; Rabinovich GA
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006646
[TBL] [Abstract][Full Text] [Related]
2. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy.
Yang R; Sun L; Li CF; Wang YH; Yao J; Li H; Yan M; Chang WC; Hsu JM; Cha JH; Hsu JL; Chou CW; Sun X; Deng Y; Chou CK; Yu D; Hung MC
Nat Commun; 2021 Feb; 12(1):832. PubMed ID: 33547304
[TBL] [Abstract][Full Text] [Related]
3. Targeting Interleukin-6 (IL-6) Sensitizes Anti-PD-L1 Treatment in a Colorectal Cancer Preclinical Model.
Li J; Xu J; Yan X; Jin K; Li W; Zhang R
Med Sci Monit; 2018 Aug; 24():5501-5508. PubMed ID: 30087314
[TBL] [Abstract][Full Text] [Related]
4. IL-17 inhibits CXCL9/10-mediated recruitment of CD8
Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K
J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response.
Qi Y; Chang Y; Wang Z; Chen L; Kong Y; Zhang P; Liu Z; Zhou Q; Chen Y; Wang J; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Dai B; Guo J; Wang Y; Xu J; Zhang W
Cancer Immunol Immunother; 2019 Dec; 68(12):2067-2080. PubMed ID: 31720813
[TBL] [Abstract][Full Text] [Related]
6.
Fong W; Li Q; Ji F; Liang W; Lau HCH; Kang X; Liu W; To KK; Zuo Z; Li X; Zhang X; Sung JJ; Yu J
Gut; 2023 Nov; 72(12):2272-2285. PubMed ID: 37770127
[TBL] [Abstract][Full Text] [Related]
7. Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis.
Hashimoto M; Kojima Y; Sakamoto T; Ozato Y; Nakano Y; Abe T; Hosoda K; Saito H; Higuchi S; Hisamatsu Y; Toshima T; Yonemura Y; Masuda T; Hata T; Nagayama S; Kagawa K; Goto Y; Utou M; Gamachi A; Imamura K; Kuze Y; Zenkoh J; Suzuki A; Takahashi K; Niida A; Hirose H; Hayashi S; Koseki J; Fukuchi S; Murakami K; Yoshizumi T; Kadomatsu K; Tobo T; Oda Y; Uemura M; Eguchi H; Doki Y; Mori M; Oshima M; Shibata T; Suzuki Y; Shimamura T; Mimori K
EBioMedicine; 2024 May; 103():105102. PubMed ID: 38614865
[TBL] [Abstract][Full Text] [Related]
8. Integrin alphavbeta6 promotes tumor tolerance in colorectal cancer.
Yang SB; Du Y; Wu BY; Xu SP; Wen JB; Zhu M; Cai CH; Yang PC
Cancer Immunol Immunother; 2012 Mar; 61(3):335-42. PubMed ID: 21913024
[TBL] [Abstract][Full Text] [Related]
9. Tumor-derived exosomes induce CD8
Maybruck BT; Pfannenstiel LW; Diaz-Montero M; Gastman BR
J Immunother Cancer; 2017 Aug; 5(1):65. PubMed ID: 28806909
[TBL] [Abstract][Full Text] [Related]
10. Unveiling YWHAH: A potential therapeutic target for overcoming CD8
Li Q; Yuan Z; Wang Y; Zhai P; Wang J; Zhang C; Shao Z; Xing C
Int Immunopharmacol; 2024 Jun; 135():112317. PubMed ID: 38796965
[TBL] [Abstract][Full Text] [Related]
11. A naturally occurring CD8(+)CD122(+) T-cell subset as a memory-like Treg family.
Li S; Xie Q; Zeng Y; Zou C; Liu X; Wu S; Deng H; Xu Y; Li XC; Dai Z
Cell Mol Immunol; 2014 Jul; 11(4):326-31. PubMed ID: 24793406
[TBL] [Abstract][Full Text] [Related]
12. Regulation of galectin-1 expression by transforming growth factor beta1 in metastatic mammary adenocarcinoma cells: implications for tumor-immune escape.
Daroqui CM; Ilarregui JM; Rubinstein N; Salatino M; Toscano MA; Vazquez P; Bakin A; Puricelli L; Bal de Kier Joffé E; Rabinovich GA
Cancer Immunol Immunother; 2007 Apr; 56(4):491-9. PubMed ID: 16900348
[TBL] [Abstract][Full Text] [Related]
13. Breaking up the CD8
Zhang C; Bockman A; DuPage M
Cancer Cell; 2024 Jun; 42(6):941-942. PubMed ID: 38861931
[TBL] [Abstract][Full Text] [Related]
14. LOXL1 promotes tumor cell malignancy and restricts CD8 + T cell infiltration in colorectal cancer.
Li C; Chen S; Fang X; Du Y; Guan XY; Lin R; Xu L; Lan P; Yan Q
Cell Biol Toxicol; 2024 Jan; 40(1):6. PubMed ID: 38267662
[TBL] [Abstract][Full Text] [Related]
15. The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide.
Zacarías Fluck MF; Hess L; Salatino M; Croci DO; Stupirski JC; Di Masso RJ; Roggero E; Rabinovich GA; Scharovsky OG
Cancer Immunol Immunother; 2012 Apr; 61(4):469-80. PubMed ID: 21947259
[TBL] [Abstract][Full Text] [Related]
16. Immune effector dysfunction signatures predict outcomes in patients with colorectal cancer.
Tang H; Wu H; Jian Y; Ji T; Wu B; Wu Y; Wang P; Cao T
Int Immunopharmacol; 2024 May; 132():111949. PubMed ID: 38552290
[TBL] [Abstract][Full Text] [Related]
17. Targeting high circDNA2v levels in colorectal cancer induces cellular senescence and elicits an anti-tumor secretome.
Wu S; Dai X; Xia Y; Zhao Q; Zhao H; Shi Z; Yin X; Liu X; Zhang A; Yao Z; Zhang H; Li Q; Thorne RF; Zhang S; Sheng W; Hu W; Gu H
Cell Rep; 2024 Apr; 43(4):114111. PubMed ID: 38615319
[TBL] [Abstract][Full Text] [Related]
18. Loss of Y in regulatory T lymphocytes in the tumor micro-environment of primary colorectal cancers and liver metastases.
Wójcik M; Juhas U; Mohammadi E; Mattisson J; Drężek-Chyła K; Rychlicka-Buniowska E; Bruhn-Olszewska B; Davies H; Chojnowska K; Olszewski P; Bieńkowski M; Jankowski M; Rostkowska O; Hellmann A; Pęksa R; Kowalski J; Zdrenka M; Kobiela J; Zegarski W; Biernat W; Szylberg Ł; Remiszewski P; Mieczkowski J; Filipowicz N; Dumanski JP
Sci Rep; 2024 Apr; 14(1):9458. PubMed ID: 38658633
[TBL] [Abstract][Full Text] [Related]
19. High expression of CDKN2A is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy.
Dong Y; Zheng M; Wang X; Yu C; Qin T; Shen X
BMC Cancer; 2023 Nov; 23(1):1097. PubMed ID: 37950153
[TBL] [Abstract][Full Text] [Related]
20. Interferon-γ in the tumor microenvironment promotes the expression of B7H4 in colorectal cancer cells, thereby inhibiting cytotoxic T cells.
Jing ZL; Liu GL; Zhou N; Xu DY; Feng N; Lei Y; Ma LL; Tang MS; Tong GH; Tang N; Deng YJ
Sci Rep; 2024 Mar; 14(1):6053. PubMed ID: 38480774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
